VTGN (VistaGen Therapeutics Inc) Net earnings per share change in current year

Corporate emblem and logo of Vistagen (VTGN)

Vistagen Therapeutics (VTGN) focuses on bringing nasal sprays for the treatment of depression and social anxiety to market. The year-over-year change in EPS exhibits volatility, with the indicator currently standing at 29.80. This trend reflects high volunteer demand in clinical trials under strict FDA oversight, although it is accompanied by risks from past failures and costs associated with secondary offerings.

Earnings per share growth in current year: Vistagen Therapeutics (VTGN) for 07/04/2022 - 11/18/2026

Comprehensive metric breakdowns and analytics for vistagen.com (VTGN)

- business market valuation indicators:
Fundamental valuation:Vistagen Therapeutics (VTGN)
Manufactured products of Vistagen Therapeutics

The reliability of equity assets is determined by the dynamics of a business's real earnings. This metric measures the percentage deviation of current earnings per share from the value of the same period last year. For Vistagen Therapeutics (VTGN), this calculation is critical, as the future scalability of drug formulas must translate into increased capital efficiency. The GURU.Markets toolkit allows users to track these changes through comparable year-over-year earnings per share growth. A positive trend in this indicator confirms the commercial viability of the biotechnological model.

Direct competitors

Earnings per share growth rate in current year Biogen Idec (BIIB)|NBIX (neurocrine.com) - Earnings growth in current year|Earnings per share growth rate in current year regencellbioscience.com RGC|Net earnings per share growth this year AXSM (Axsome Therapeutics, Inc.)|ACAD (ACADIA Pharma) - Earnings per share increase in current year|Earnings growth in current year XENE (Xenon Pharmaceuticals Inc)|Net earnings per one share growth for the current year VKTX (Viking Pharma)|SUPN: Net earnings per share growth this year|Earnings per share increase in current year CPRX (catalystpharma.com)|DNLI: Earnings growth in current year|HRMY - Expected net earnings per share growth this year|Net earnings per share growth this year BHVN|AMLX: Earnings per share increase in current year|Earnings per share growth in current year Trevi Pharma (TRVI)|Expected net earnings per share growth this year praxismedicines.com|Earnings per share growth in current year Anavex AVXL|Expected net earnings per share growth this year CeriBell (CBLL)|PRTA - Earnings per share growth in current year|ALEC: Earnings per share growth in current year|Annexon (ANNX) - Earnings per share growth in current year|OMER: Net earnings per one share growth for the current year|NGNE (neurogene.com) - Earnings growth in current year|Earnings growth in current year AC Immune S.A.|Net earnings per share growth this year VYGR (Voyager Therapeutics, Inc.)|Net earnings per one share growth for the current year NMRA|Earnings per share growth in current year scilexholding.com SCLX|TVGN: Earnings per share growth this year|alphacognition.com - Earnings growth in current year|Cognition Therapeutics - Net earnings per one share growth for the current year|IKT: Earnings growth in current year|Net earnings per share growth this year Cassava Sciences, Inc.|ASRT (assertiotx.com) - Earnings growth in current year|Net earnings per share growth this year Coya Therapeutics (COYA)|Net earnings per share growth this year OVID (Ovid Rx)|Expected net earnings per share growth this year Acumen Pharmaceuticals, Inc.|Earnings growth in current year CRVO (CervoMed Corporation)|Net earnings per one share growth for the current year ATHE (Alterity Therapeutics Ltd)|Clene Nanomedicine - Earnings growth in current year|Net earnings per share change in current year pepgen.com (PEPG)|JUNS: Earnings growth in current year|Earnings per share growth this year RLMD|ANVS (Annovis Bio Inc) - Earnings growth in current year|Net earnings per share growth this year Grace Therapeutics, Inc. (GRCE)|Earnings growth in current year AIFF|Net earnings per one share growth for the current year KLTO|Earnings per share growth in current year neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings (RVPH) - Earnings per share growth rate in current year|MetaVia Inc. - Earnings growth in current year|Expected net earnings per share growth this year NeurAxis Inc NRXS|HSDT (Helius Medical Technologies Inc.) - Net earnings per share growth this year|Passage Bio Inc. (PASG) - Earnings growth in current year|Earnings per share growth in current year Neuphoria|Net earnings per share growth this year Minerva Neurosciences, Inc. (NERV)|Earnings per share growth in current year Athira (ATHA)|Addex Therapeutics - Earnings per share growth this year|Earnings per share growth in current year Alzamend Neuro, Inc. ALZN|Cyclerion (CYCN) - Earnings per share growth rate in current year|PTIX - Earnings per share growth in current year|Expected net earnings per share growth this year Pasithea Therapeutics Corp KTTA|Cortigent, Inc. (CRGT) - Earnings per share growth in current year|Avenue Therapeutics - Earnings per share increase in current year|BCLI (brainstorm-cell.com) - Earnings growth in current year|CARA: Earnings per share increase in current year|Earnings per share growth in current year Chromocell Therapeutics Corp (CHRO)|ELYM (Eliem Therapeutics Inc.) - Earnings per share increase in current year|Earnings growth in current year ITCI (Intra-Cellular Therapies Inc.)|Net earnings per share change in current year Longboard Pharma|MRNS - Earnings per share growth in current year|NKGen Biotech, Inc. (NKGN) - Net earnings per share growth this year|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net earnings per share growth this year|Sage Therapeutics - Earnings per share increase in current year|Earnings per share growth in current year Synaptogenix, Inc.|TRVN: Earnings per share increase in current year|Earnings growth in current year VIGL|Net earnings per share growth this year Anew Medical, Inc. WENA|Earnings per share growth in current year Cerevel Therapeutics CERE